Hep C Treatments Save Care Costs if Administered Early

Share this post

The early initiation of a pan-genotypic regimen lowers the cost of future care, report health economists who say current policies that base access to treatment on disease stage might be short-sighted.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Share this post

Be the first to comment

Leave a Reply